(PRESS RELEASE) CHARENTON-LE-PONT, FRANCE — Thanks to their partnership, the WSPOS* independent medical education program content on myopia management is now fully available on EssilorLuxottica’s open-learning platform, Leonardo which provides the vision care industry with learning content designed and taught by industry experts. This will contribute to further educate and help eye care professionals successfully integrate myopia management in practice and guide their patients on how to best manage their myopia.
This year, the program also features a digital supplement, three e-learning modules and three 60-minute webinars, which will also be available on Leonardo.
As part of its long-standing efforts to advance evidence-based myopia education globally, EssilorLuxottica has partnered with WSPOS every year since 2020, in a commitment to share knowledge and insights on myopia control interventions such as Essilor Stellest, actively participating in their annual congresses and sub-speciality days. EssilorLuxottica is also a gold-level supporter of the WSPOS independent medical education program.
“We are pleased to continue our long-standing partnership with WSPOS, an organization that shares our vision to contribute to better vision for children. As part of our partnership to advance myopia education, the WSPOS medical education program content on myopia management is available globally for eye care professionals through our learning platform, Leonardo,” said Olga Prenat, head, medical and professional affairs and vision care education, EssilorLuxottica. “We look forward to accomplishing more together this year to contribute to widespread adoption of myopia management.”
Dr. Ken K. Nischal, WSPOS co-founder and division chief, pediatric ophthalmology, strabismus, and adult motility, professor of ophthalmology at the University of Pittsburgh, School of Medicine, said: “Myopia management is an extremely important component of WSPOS’s public health initiatives and we are delighted to have support from EssilorLuxottica for our Myopia IME.”